INO

Inovio Pharmaceuticals Inc.

Price

$1.91

return (12m)

-23.80%

p/e

-0.83

p/bv

12.83

DIVIDEND YIELD

0.00%

INO price

Inovio Pharmaceuticals

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*The amount considers the reinvestment of dividends.

Return on Investment INO

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

70.09%

3 months

184.37%

1 year

-23.80%

2 years

-65.05%

5 years

-97.63%

10 years

-97.53%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals INO

Valuation

P/E

-0.83

Sector -3.16

Industry -3.16

P/BV

12.83

Sector 1.80

Industry 1.80

P/Revenue (PSR)

Sector 2.04

Industry 2.04

EV/EBITDA

-0.30

Sector -204.34

Industry -204.34

EV/EBIT

-0.29

Sector -42.58

Industry -42.58

P/EBITDA

-0.87

Sector -19.73

Industry -19.73

P/EBIT

-0.83

Sector -67.09

Industry -67.09

P/Total Assets

1.14

Sector 1.06

Industry 1.06

P/Net Current Assets

-10.99

Sector -9.56

Industry -9.56

P/Working Capital

-28,048.41

Sector -93.82

Industry -93.82

EPS

-0.83

Sector -1.78

Industry -1.78

BVPS

0.05

Sector 1.99

Industry 1.99

Efficiency

Gross Margin

0.00%

Sector 41.28%

Industry 41.28%

EBITDA Margin

Sector -21,198.78%

Industry -21,198.78%

EBIT Margin

0.00%

Sector -35.28%

Industry -35.28%

Net Profit Margins

0.00%

Sector -35.71%

Industry -35.71%

Asset Turnover

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

-409.87%

Sector -61.32%

Industry -61.32%

ROA

-114.64%

Sector -54.29%

Industry -54.29%

ROIC

-168.07%

Sector -1,801.33%

Industry -1,801.33%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

1.00

Sector 2.91

Industry 2.91

Net Debt / EBITDA

0.57

Sector -20.38

Industry -20.38

Net Debt / EBIT

0.54

Sector -4.13

Industry -4.13

Net Debt / Equity

-8.39

Sector -33,112.98

Industry -33,112.98

Gross Debt / Equity

0.00

Sector -0.64

Industry -0.64

Equity/Assets

0.09

Sector 0.46

Industry 0.46

Liabilities/Assets

0.91

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

-25.99%

Sector -

Industry -

Fundamentals INO

DRAG THE FRAME TO SEE MORE DATA

Assets	Price ($)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
INO Inovio Pharmaceuticals Inc.	$1.91	-18.94%	0.00%	-0.83	12.83	-409.87%	0.00%
PFE Pfizer Inc.	$30.41	33.97%	5.73%	39.46	2.00	4.97%	6.80%
ABBV AbbVie Inc.	$288.29	36.44%	2.31%	53.66	0.00	-%	14.76%
NVO Novo Nordisk A/S	$40.49	-13.45%	4.66%	9.73	5.17	60.28%	35.32%
MRK Merck & Co. Inc.	$145.20	73.83%	2.27%	116.34	8.79	6.97%	4.77%
AZN AstraZeneca PLC	$185.11	15.21%	1.73%	22.38	5.77	27.27%	16.95%
BMY Bristol-Myers Squibb Company	$62.63	41.99%	5.06%	13.78	5.44	44.06%	18.47%
ZTS Zoetis Inc.	$83.43	-40.99%	2.60%	12.71	10.64	64.91%	27.69%
AMGN Amgen Inc.	$464.48	60.80%	2.13%	28.86	21.58	91.47%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$973.63	52.20%	0.41%	21.68	2.96	14.04%	27.86%
HALO Halozyme Therapeutics Inc.	$130.37	99.98%	0.00%	37.10	106.90	173.67%	24.86%
MCK McKesson Corporation	$1,008.67	24.93%	0.34%	25.96	-30.85	-168.45%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$536.30	26.02%	0.00%	32.22	7.01	23.54%	35.00%
CAH Cardinal Health Inc.	$255.97	35.45%	0.81%	34.74	-21.86	-63.98%	0.67%
ARGX argenx SE	$883.95	8.00%	0.00%	13.26	-	-%	25.42%
HRMY Harmony Biosciences Holdings Inc.	$38.00	33.01%	0.00%	12.39	2.25	20.46%	18.88%
BIIB Biogen Inc.	$251.87	63.27%	0.00%	45.08	2.00	4.58%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

INO - Historical Dividends

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	09/27/2017	10/16/2017	0.82800000
Dividends	08/29/2017	09/15/2017	0.82800000

ABOUT Inovio Pharmaceuticals

Inovio Pharmaceuticals Inc.

Average Investor10 user rating

5.0 (3 people)

United States

43 years

Founded: 1983

1998

Time since IPO - 28 years

190

Employees

Inovio Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $56.10 million, with shareholders equity totaling $4.37 million.

The company employs approximately 190 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Inovio Pharmaceuticals Inc. reported $- in revenue, generating net income of $-67.43 million.

Key financial metrics include a P/E ratio of -0.83, a price-to-book (P/B) ratio of 12.83, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker INO.

Market cap

$56.10 million

Net worth

$4.37 million

$4,371,000.00

Assets

$49.39 million

$49,389,000.00

Total Shares Outstanding

81.62 million

81,619,000

Average Daily Trading Volume

$4.96 million

$4,963,828.02

Sector

Health Care

Industry

Biotechnology

INO

INO revenue and profits

Financial Results INO

DRAG THE FRAME TO SEE MORE DATA

INO cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$1,008.67 23,56% (12M)

P/E

25.96

0.34%

ROE

-168.45%

P/BV

-30.85

CAH - Cardinal Health

$255.97 35,84% (12M)

P/E

34.74

0.81%

ROE

-63.98%

P/BV

-21.86

ABBV - AbbVie

$288.29 40,35% (12M)

P/E

53.66

2.31%

ROE

P/BV

0.00

MRK - Merck & Co.

$145.20 81,18% (12M)

P/E

116.34

2.27%

ROE

6.97%

P/BV

8.79

AZN - AstraZeneca

$185.11 16,02% (12M)

P/E

22.38

1.73%

ROE

27.27%

P/BV

5.77

PFE - Pfizer

$30.41 33,92% (12M)

P/E

39.46

5.73%

ROE

4.97%

P/BV

2.00

BMY - Bristol-Myers Squibb

$62.63 42,14% (12M)

P/E

13.78

5.06%

ROE

44.06%

P/BV

5.44

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$1,008.67 23,56% (12 M)

P/L

25.96

0.34%

ROE

-168.45%

P/VP

-30.85

CAH - Cardinal Health

$255.97 35,84% (12 M)

P/L

34.74

0.81%

ROE

-63.98%

P/VP

-21.86

ABBV - AbbVie

$288.29 40,35% (12 M)

P/L

53.66

2.31%

ROE

P/VP

0.00

MRK - Merck & Co.

$145.20 81,18% (12 M)

P/L

116.34

2.27%

ROE

6.97%

P/VP

8.79

AZN - AstraZeneca

$185.11 16,02% (12 M)

P/L

22.38

1.73%

ROE

27.27%

P/VP

5.77

PFE - Pfizer

$30.41 33,92% (12 M)

P/L

39.46

5.73%

ROE

4.97%

P/VP

2.00

BMY - Bristol-Myers Squibb

$62.63 42,14% (12 M)

P/L

13.78

5.06%

ROE

44.06%

P/VP

5.44

Frequently Asked Questions

What is the price of Inovio Pharmaceuticals (INO) today?

The current price of Inovio Pharmaceuticals (INO) is $1.91. The stock began the year trading around $1.74 and is currently priced at $1.91. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Inovio Pharmaceuticals (INO) pay dividends?

Inovio Pharmaceuticals (INO) did not pay dividends over the past year.

Is Inovio Pharmaceuticals (INO) a good investment?

Inovio Pharmaceuticals (INO) is currently trading at $1.91 with a P/E ratio of -0.83. This represents a -99% premium compared to its historical average P/E. Over the past year, the stock paid $0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was -23.80%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Inovio Pharmaceuticals (INO) stock?

You can buy Inovio Pharmaceuticals (INO) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol INO and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Inovio Pharmaceuticals (INO) yield today?

Over the past month, Inovio Pharmaceuticals (INO) has returned 70.09% — -23.80% over the past year, and -97.63% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of Inovio Pharmaceuticals (INO) today at the current price of $1.91 your total investment would be $190.50.

Based on historical performance, the investment would have grown to approximately:

$145.16 after 1 year
$4.51 after 5 years
$4.71 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

INO

Inovio Pharmaceuticals Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment INO

Target price created!

Delete target price?

Your Target Price strategy deserves unlimited alerts

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING INO WITH OTHER STOCKS

type

Ex - Dividend Date

payment date

value

ABOUT Inovio Pharmaceuticals

Inovio Pharmaceuticals Inc.

United States

43 years

1998

190

PROFIT X PRICE INO

Financial Results INO

INO cash flow

Asset, Revenue and Profit Growth - INO

INO balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BMY - Bristol-Myers Squibb

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BMY - Bristol-Myers Squibb

Frequently Asked Questions